Abstract
Lung cancer is the most common and one of the leading causes of death from cancer around the world according to the latest published data of “International Agency for Research on Cancer” (IARC) [1]. There are four major histologic types of lung cancer. These are squamous cell carcinoma, adenocarcinoma, small cell carcinoma, and large cell carcinoma [2]. Successful treatment of lung cancer is related with early diagnosis and stage. Early diagnosis has increased with the widespread use of imaging methods, especially computed tomography (CT) and position emission tomography (PET) [3]. In this context, lung cancer screening has an important role in the detection of patients who can be cured with surgery. Stage IA-IIB non-small cell lung cancer is considered as an early stage according to the latest published eighth lung cancer tumor, node, and metastasis (TNM) classification [4]. These early-stage lung cancers constitute 20–25% of all lung cancers. The primary treatment of these groups is surgical resection due to the highest probability of cure. In some special situations, surgical indications are also present in stages III and IV. In this context, all patients should be carefully evaluated in terms of staging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
World Health Organization [web site]. International Agency for Research on Cancer (IARC) Globocan 2018, Section of Cancer Information. Cancer Incidence and Mortality Worldwide; 2018. Web site: http://globocan.iarc.fr/
Travis WD, Brambilla E, Burke AP, et al. WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. Lyon: International Agency for Research on Cancer; 2015.
National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. https://doi.org/10.1056/NEJMoa1102873. Epub 2011 Jun 29. PMID: 21714641; PMCID: PMC4356534
Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):138–55. https://doi.org/10.3322/caac.21390. Epub 2017 Jan 31
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
Zhang L, Wu F, Zhu R et al. Mediastinal N Staging Assessment Working Group. Application of computed tomography, positron emission tomography-computed tomography, magnetic resonance imaging, endobronchial ultrasound, and mediastinoscopy in the diagnosis of mediastinal lymph node staging of non-small-cell lung cancer: a protocol for a systematic review. Medicine (Baltimore). 2020;99(9):e19314. https://doi.org/10.1097/MD.0000000000019314.
Ozturk A, Gullu YT. Excellence in non-small cell lung cancer staging by endobronchial-TBNA: comparison with PET-CT and surgery. Minim Invasive Ther Allied Technol. 2018;4:213–9.
Venissac N, Alifano M, Mouroux J. Video-assisted mediastinoscopy: experience from 240 consecutive cases. Ann Thorac Surg. 2003;76:208–12.
Anraku M, Miyata R, Compeau C, Shargall Y. Video-assisted mediastinoscopy compared with conventional mediastinoscopy: are we doing better? Ann Thorac Surg. 2010;89:1577–81.
Adams K, Shah PL, Edmonds L, Lim E. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax. 2009;64:757–62.
Chandra S, Nehra M, Agarwal D, Mohan A. Diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle biopsy in mediastinal lymphadenopathy: a systematic review and meta-analysis. Respir Care. 2012;57:384–91. GUIDELINE De Leyn P et al. Eur J Cardiothoracic Surg 797. Downloaded from https://academic.oup.com/ejcts/article/45/5/787/407588 by guest on 19 October 2020.
Zhang R, Ying K, Shi L, Zhang L, Zhou L. Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal lymph node staging of lung cancer: a meta-analysis. Eur J Cancer. 2013;49:1860–7.
Shingyoji M, Nakajima T, Yoshino M, et al. Endobronchial ultrasonography for positron emission tomography and computed tomography– negative lymph node staging in non-small cell lung cancer. Ann Thorac Surg. 2014;98:1762–7.
Herth FJ, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest. 2008;133:887–91.
Rami-Porta R, Wittekind C, Goldstraw P, International Association for the Study of Lung Cancer (IASLC) Staging Committee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer. 2005;49(1):25–33. https://doi.org/10.1016/j.lungcan.2005.01.001. PMID: 15949587.
Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141:662–70.
Heineman DJ, Daniels JM, Schreurs WH. Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy. Ther Adv Med Oncol. 2017;9:599–609.
Matsuoka H, Nishio W, Okada M, et al. Resection of chest wall invasion in patients with non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;26(6):1200–4.
Lee CY, Byun CS, Lee JG, et al. The prognostic factors of resected non-small cell lung cancer with chest wall invasion. World J Surg Oncol. 2012;10:9. https://doi.org/10.1186/1477-7819-10-9. Published online 2012 Jan 12.
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann Thorac Surg. 1995;60:615–22; discussion 622–3.
Gómez MT, Jiménez MF, Aranda JL, et al. The risk of bilobectomy compared with lobectomy: a retrospective analysis of a series of matched cases and controls. Eur J Cardiothorac Surg. 2014;46(1):72–5. https://doi.org/10.1093/ejcts/ezt521. Epub 2013 Nov 15.
Li Z, Chen W, Xia M, et al. Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis. Transl Lung Cancer Res. 2019;8(6):775–86. https://doi.org/10.21037/tlcr.2019.10.11.
Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e278S–313S.
Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg. 2001;71:956–60; discussion 961.
Schuchert MJ, Pettiford BL, Keely S, et al. Anatomic segmentectomy in the treatment of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2007;84:926–32; discussion 932–3.
Detterbeck FC, Chansky K, Groome P et al. IASLC Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions. The IASLC lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (eighth) edition of the TNM classification of lung cancer. J Thorac Oncol. 2016;11(9):1433–46. https://doi.org/10.1016/j.jtho.2016.06.028. Epub 2016 Jul 21.
Chan EG, Chan PG, Mazur SN et al. Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020. pii: S0022-5223(20)30706-6. https://doi.org/10.1016/j.jtcvs.2020.03.041.
Mohiuddin K, Haneuse S, Sofer T, Swanson SJ et al. Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014;147(4):1169–75; discussion 1175–7. https://doi.org/10.1016/j.jtcvs.2013.11.056. Epub 2014 Jan 2.
Moon Y, Lee KY, Park JK. The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection. J Thorac Dis. 2017;9(10):3782–92.
Sagawa M, Oizumi H, Suzuki H, et al. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Eur J Cardiothorac Surg. 2018;53(4):849–56. https://doi.org/10.1093/ejcts/ezx418.
Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):314–40.
Wang Z, Gao SG, Xue Q, et al. Surgery of primary non-small cell lung cancer with oligometastasis: analysis of 172 cases. J Thorac Dis. 2018;10(12):6540–6. https://doi.org/10.21037/jtd.2018.11.125.
Ashworth AB, Senan S, Palma DA, et al. An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer. Clin Lung Cancer. 2014;15(5):346–55.
Couñago F, Luna J, Guerrero LL, et al. Management of oligometastatic non-small cell lung cancer patients: current controversies and future directions. World J Clin Oncol. 2019;10(10):318–39.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Çetinkaya, Ç., Batırel, H.F. (2023). Surgical Treatment for Lung Cancer. In: Cingi, C., Yorgancıoğlu, A., Bayar Muluk, N., Cruz, A.A. (eds) Airway Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-22483-6_65-1
Download citation
DOI: https://doi.org/10.1007/978-3-031-22483-6_65-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-22482-9
Online ISBN: 978-3-031-22483-6
eBook Packages: MedicineReference Module Medicine